New Research Progress in Mycoplasma pneumoniae Infection

As an important pathogen of respiratory tract infection, Mycoplasma pneumoniae (MP) may not only lead to primary atypical pneumonia but also cause systemic organ conditions. MP causes respiratory tract infection among school-age children and is also an important infectious agent for adult respirator...

Full description

Bibliographic Details
Main Author:	Li Fengtan
Format:	Article
Language:	English
Published:	Sciendo 2015-12-01
Series:	Infection International
Subjects:	Mycoplasma pneumoniae infection treatment immune response
Online Access:	http://www.degruyter.com/view/j/ii.2015.4.issue-4/ii-2017-0114/ii-2017-0114.xml?format=INT

id	doaj-81dc8595623e40b6b33b60d90b50d7b6
record_format	Article
spelling	doaj-81dc8595623e40b6b33b60d90b50d7b62020-11-24T23:14:17ZengSciendoInfection International2544-03492015-12-0144919510.1515/ii-2017-0114ii-2017-0114New Research Progress in Mycoplasma pneumoniae InfectionLi Fengtan0Department of Radiology, Tianjin Medical University General Hospital, Tianjin, ChinaAs an important pathogen of respiratory tract infection, Mycoplasma pneumoniae (MP) may not only lead to primary atypical pneumonia but also cause systemic organ conditions. MP causes respiratory tract infection among school-age children and is also an important infectious agent for adult respiratory tract infection. Intensive studies on roles of MP infection on the innate immune system significantly aid development of targeted therapy drugs. Epidemic studies on associated symptoms also help in clinical prevention and diagnosis and show importance to personalized treatment utilizing different drugs for different patients. This study summarizes the abovementioned three points based on MP studies in recent years.http://www.degruyter.com/view/j/ii.2015.4.issue-4/ii-2017-0114/ii-2017-0114.xml?format=INTMycoplasma pneumoniaeinfectiontreatmentimmune response
collection	DOAJ
language	English
format	Article
sources	DOAJ
author	Li Fengtan
spellingShingle	Li Fengtan New Research Progress in Mycoplasma pneumoniae Infection Infection International Mycoplasma pneumoniae infection treatment immune response
author_facet	Li Fengtan
author_sort	Li Fengtan
title	New Research Progress in Mycoplasma pneumoniae Infection
title_short	New Research Progress in Mycoplasma pneumoniae Infection
title_full	New Research Progress in Mycoplasma pneumoniae Infection
title_fullStr	New Research Progress in Mycoplasma pneumoniae Infection
title_full_unstemmed	New Research Progress in Mycoplasma pneumoniae Infection
title_sort	new research progress in mycoplasma pneumoniae infection
publisher	Sciendo
series	Infection International
issn	2544-0349
publishDate	2015-12-01
description	As an important pathogen of respiratory tract infection, Mycoplasma pneumoniae (MP) may not only lead to primary atypical pneumonia but also cause systemic organ conditions. MP causes respiratory tract infection among school-age children and is also an important infectious agent for adult respiratory tract infection. Intensive studies on roles of MP infection on the innate immune system significantly aid development of targeted therapy drugs. Epidemic studies on associated symptoms also help in clinical prevention and diagnosis and show importance to personalized treatment utilizing different drugs for different patients. This study summarizes the abovementioned three points based on MP studies in recent years.
topic	Mycoplasma pneumoniae infection treatment immune response
url	http://www.degruyter.com/view/j/ii.2015.4.issue-4/ii-2017-0114/ii-2017-0114.xml?format=INT
work_keys_str_mv	AT lifengtan newresearchprogressinmycoplasmapneumoniaeinfection
_version_	1725595163534819328

New Research Progress in Mycoplasma pneumoniae Infection

Similar Items